Details of the Drug
General Information of Drug (ID: DMUE4K3)
Drug Name |
4,5,6,7-tetrabromo-1H-benzimidazole
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4,5,6,7-tetrabromobenzimidazole; TBBz; 577779-57-8; 4,5,6,7-Tetrabromo-Benzimidazole; 4,5,6,7-tetrabromo-1H-benzo[d]imidazole; CHEMBL373937; 2oxy; AC1NP4E4; SCHEMBL406945; CTK5I6050; DTXSID80408803; MolPort-003-850-464; LOEIRDBRYBHAJB-UHFFFAOYSA-N; HMS3260K22; ZINC2528524; Tox21_500140; BDBM50156669; TBBz, > MFCD04116202; 4,5,6,7-Tetrabromo-1Hbenzimidazole; LP00140; CCG-221444; NCGC00260825-01; NCGC00165910-02; NCGC00165910-01; RT-009016; FT-0674936
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 433.72 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 4.3 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 0 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References